October 3, 2024

Safety and efficacy of coated flow diverters in the treatment of cerebral aneurysms during single antiplatelet therapy: A multicenter study

Key Points

Key points are not available for this paper at this time.

Abstract

This multicenter study evaluates the safety and efficacy of coated flow diverters (cFDs) for the treatment of cerebral aneurysms under single antiplatelet therapy (SAPT).

AIに質問

Bookmark

Cite This Study

Goertz et al. (Thu,) studied this question.

synapsesocial.com/papers/68e55db8e2b3180350efb530 https://doi.org/https://doi.org/10.1177/15910199241286542

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience2020 · 37 citations
2Pipeline Vantage Embolization Device for the treatment of intracranial aneurysms: A systematic review and meta-analysis2024 · 8 citations
3Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience2018 · 127 citations
4Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study2018 · 26 citations
5Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial2013 · 1,095 citations

AIに質問

Bookmark